Company news

Genetic Signatures Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Appendix 4C - quarterly

January 29, 2019

CE-IVD Mark for Respiratory Pathogen Detection Kit

December 16, 2018

$2.6m R&D refund received

December 7, 2018

Chairmans Address to Shareholders

November 29, 2018

Investor presentation

November 25, 2018

Appendix 4E and 2018 Financial Report

August 28, 2018

Additional Tax Incentive from understatement FY17 R&D Claim

August 23, 2018

Investor Presentation

August 14, 2018

Update to major customer contract announcement

August 3, 2018

Major Customer Contract Signed, New Kit and Instrument

August 1, 2018

TGA registration for superbug detection kits

May 14, 2018

Positive Trial Results Presented at ECCMID

April 25, 2018

Appendix 4D and Half Year Financial Statements

February 27, 2018

2017 AGM Presentation

November 27, 2017

Appendix 4E and 2017 Financial Report

August 30, 2017

Regulatory and Patent approval

June 19, 2017

Results of Flavivirus Clinical Trial

April 23, 2017

GSS Launches Sexually Transmitted Infection (STI) Kit

March 30, 2017

Appendix 4D - Half Yearly Report and Accounts

February 26, 2017

2016 AGM MD and CEO Presentation

November 28, 2016

STI Detection Kit Clinical Validation Trial Results

October 18, 2016

Open Briefing - Capital Raising and Company Outlook

September 28, 2016

Clinical Validation of Sexual Health Detection Kit Commenced

September 26, 2016

Completion of $14m capital raising

September 1, 2016

UCLA to launch Genetic Signatures technology

June 23, 2016

GSS launches Analyte Specific Reagents in US

June 16, 2016

Collaboration with UCLA

February 11, 2016

Appendix 4E and Audited Financial Report

February 10, 2016

← Newer news releases

Calls

Decks

The 5 newest of 47 decks. Every deck is listed under its year.